IMPACT OF PATIENT NONADHERENCE TO DIABETES TREATMENT ON COMPLICATION RISKS AND HEALTH CARE COSTS
Author(s)
Mizobe M, Fukuda H
Kyushu University, Fukuoka, Japan
OBJECTIVES: To investigate the association between nonadherence to diabetes treatment and the occurrence of diabetes complications. METHODS: Our study retrospectively identified adherence and nonadherence to diabetes treatment in patients during the first year of observation after new diagnoses of type 2 diabetes, and compared the occurrence of complications and healthcare expenditure between adherent and nonadherent patients for the second to eighth years. Study participants were insurance enrollees with type 2 diabetes who received healthcare between 2005 and 2013, and who could be tracked for more than 12 months from the initiation of diabetes treatment. We measured occurrence of diabetes-related complications (retinopathy, nephropathy, neuropathy, ischemic heart disease, cerebrovascular disease, and chronic arterial occlusion) and all-cause healthcare expenditure. Cox proportional hazards regression models were used to investigate the effects of nonadherence on complication occurrence. To analyze the effects of nonadherence on the cumulative healthcare expenditure according to the number of elapsed years, we developed a generalized linear model (GLM) with a log-link function and gamma distribution. RESULTS: We identified 1,784 nonadherent patients and 9,547 adherent patients. Cox proportional hazard models showed that the occurrence of microvascular complications was significantly higher in the nonadherent group: the hazard ratios (95% confidence intervals) for retinopathy, nephropathy, and neuropathy were 2.04 (1.57–2.66), 1.91 (1.35–2.72), and 1.83 (1.02–3.27), respectively. However, no significant differences were observed between the adherent and nonadherent groups for the macrovascular complications (ischemic heart disease, cerebrovascular disease, and chronic arterial occlusion). In addition, the nonadherent group had a significantly higher cumulative healthcare expenditure than the adherent group during the second-to-fifth–year period (p = 0.029) and the second-to-sixth–year period (p = 0.009) after treatment initiation. CONCLUSIONS: Nonadherence in the first year of diabetes can increase the incidence of complications and result in higher expenditures for patients and payers.
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PHS130
Topic
Economic Evaluation, Health Service Delivery & Process of Care
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Health Care Research, Hospital and Clinical Practices
Disease
Diabetes/Endocrine/Metabolic Disorders